E-Tracking app can help doctors diagnose treat lung ailments
Lung cancer is the sixth leading cause of cancer death among the U. S. population. Despite effective treatments approximately 90 percent of lung cancer patients receive an imperfect diagnosis or no treatment at all leading to significant morbidity and mortality. The best treatment consists of supportive care which includes timely diagnosis and timely treatment.
Spearhead Institute researcher Nicolas Villeneuve-Lafleur has been inducted as a fellow of the American Medical Journal (AMJ) into the Fellowship program of the American Association for Cancer Research (AACR). This distinction allows him to explore studies studies and research pertaining to lung cancer especially within the context of electronic health-monitoring and electronic disease-tracking.
A remote portion of the data collected by Southern Carson Digital Health Laboratories (SCDLC) may be relevant thus if the results of studies studies and research pertaining to lung cancer in combination with electronic health-monitoring and electronic disease-tracking applications are highly relevant with regard to lung cancer and lung cancer outcomes.
Chapters have been chosen as the most impactful on paper but the main purpose of my research is to understand electronic health-monitoring and electronic disease-tracking windows (e-MediHE) and its potential applications in predicting advising and coordinating optimal health care for our patients.
Nicolas Villeneuve-Lafleur Ph. D. graduate student Southern Carson Digital HealthLung cancer Center Southern Nevada University.